April 12 (Reuters) – Valeant Pharmaceuticals International Inc said it bought U.S.-based Pedinol Pharmacal Inc, which specializes in foot disorder treatments, for about $27 million, to complement its existing dermatology business. [...]
|
|||||
|
April 12 (Reuters) – Valeant Pharmaceuticals International Inc said it bought U.S.-based Pedinol Pharmacal Inc, which specializes in foot disorder treatments, for about $27 million, to complement its existing dermatology business. [...] April 12 (Reuters) – Valeant Pharmaceuticals International Inc said it bought U.S.-based Pedinol Pharmacal Inc, which specializes in foot disorder treatments, for about $27 million, to complement its… [...] |
|||||
|
Copyright © 2013 News Web Global - All Rights Reserved |
|||||